We separately analyzed HR-proficient and HR-deficient breast cancers, as assessed by the CHORD algorithm57 (Fig. 6A), or by BRCA1/2 mutation status (Supplementary Fig. 6A). This evidence concerns the gene BRCA1 and breast cancer.